This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Management of household and sexual contacts

Authoring team

Management of household and sexual contacts

  • for household and sexual contacts who haven't received two doses of hepatitis A vaccine (or one dose within the past six months), do not have a history of laboratory confirmed hepatitis A and are seen within 14 days of exposure to infection:

    • healthy persons aged 12 months to 50 years
      • a single dose of monovalent hepatitis A vaccine should be given
      • if the patient is at continued risk of infection a second dose of vaccine at 6-12 months after the first dose should be advised

    • healthy infants <12 months
      • post exposure prophylaxis is not required

    • people aged over 50 years
      • monovalent hepatitis A vaccine + normal immunoglobulin (HNIG)
      • should receive a second dose at 6-12 months to ensure long term protection

    • people with chronic liver disease, pre existing chronic hepatitis B or C infection or HIV infection or immunosupression
      • monovalent hepatitis A vaccine + normal immunoglobulin (HNIG)
      • should receive a second dose at 6-12 months to ensure long term protection

    • pregnant or breast feeding women
      • same as for non pregnant contacts

    • for household contacts seen 14 days after exposure to infection:
      • consider HNIG up to 28 days post exposure for people with risk of severe disease (with chronic liver disease or pre existing hepatitis B or C)
        • two doses of hepatitis A vaccine given 6 months apart should also be considered in these patients to provide long term protection (irrespective of the time since exposure)
      • if there is more than one contact in the household, offer vaccination for all contacts seen within 8 weeks of onset of symptoms in the index case
      • household contact who attends nursery or infant school - proper hand washing technique (under supervision) should be followed to reduce the risk of asymptomatic transmission

    • for wider communities to control outbreaks
      • monovalent hepatitis A vaccine should be given (with the second dose given at 6-12 months if contacts are at continuing risk)
      • those who are at risk of severe infection additional HNIG should be offered (1)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.